title: In Reply.
authors.affiliation: Department of Infectious Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
authors.forename: Fereshte
authors.initials: F
authors.lastname: Sheybani
authors.forename: MohammadReza
authors.initials: M
authors.lastname: Sarvghad
authors.forename: HamidReza
authors.initials: H
authors.lastname: Naderi
authors.forename: Masoumeh
authors.initials: M
authors.lastname: Gharib
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D058890:Granulomatous Mastitis / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate